Propiedad y actividad de insiders de GT Biopharma, Inc. (GTBP): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $7.81 |
| Capitalización | $10M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $19000 | $576000 | $60000 | $28000 | $5.3M | $9.0M | $5.7M | $1.1M | $4.0M | $6.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $23.0M | $10.8M | $12.9M | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $21000 | $576000 | $90000 | $274000 | $5.7M | $32.2M | $16.6M | $14.1M | $4.2M | $8.1M |
| Inmovilizado Material | $4000 | $6000 | $35000 | $110000 | 0 | 0 | $165000 | $53000 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $253.8M | $25.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $25000 | $254.4M | $25.4M | $396000 | $5.7M | $32.2M | $16.7M | $14.1M | $4.2M | $8.1M |
| Cuentas por Pagar | $2.1M | $2.5M | $1.8M | $1.9M | $2.2M | $8.2M | $3.1M | $4.3M | $3.9M | $748000 |
| Deuda a Corto | $12.4M | $31000 | $10.8M | $13.2M | $26.3M | $31000 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $18.9M | $2.7M | $14.0M | $19.7M | $35.1M | $10.3M | $4.9M | $6.6M | $5.9M | $2.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $18.9M | $2.7M | $14.0M | $19.7M | $35.1M | $10.3M | $5.0M | $6.6M | $5.9M | $2.3M |
| Reservas | -$124.6M | -$269.5M | -$528.7M | -$567.3M | -$595.6M | -$653.6M | -$674.5M | -$682.1M | -$695.2M | -$723.9M |
| Patrimonio Neto | -$18.8M | $251.9M | $11.5M | -$19.1M | -$29.3M | $21.9M | $11.7M | $7.5M | -$1.7M | $5.8M |
| Deuda Total | $12.4M | $31000 | $10.8M | $13.4M | $26.3M | $31000 | $174000 | $58000 | 0 | 0 |
| Deuda Neta | $12.4M | -$545000 | $10.7M | $13.3M | $21.0M | -$31.9M | -$16.3M | -$13.9M | -$4.0M | -$6.8M |
| Capital Circulante | -$18.9M | -$2.1M | -$13.9M | -$19.4M | -$29.4M | $21.9M | $11.6M | $7.4M | -$1.7M | $5.8M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 2.61 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -128.11 |
Rentabilidad
| Rentabilidad sobre capital | -443.08% |
| Rentabilidad sobre capital invertido | -457.75% |
| Rentabilidad sobre activos | -381.53% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ARTL · CARM · DRMA · LIPO · PBM · PTIX · REVB
Explorar sector: Healthcare · Biotechnology
Más secciones de GTBP: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones